Related Experiment Video
Updated: Sep 6, 2025

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
miRNA Involvement in Cerebral Ischemia-Reperfusion Injury
Maria-Adriana Neag1, Andrei-Otto Mitre2, Codrin-Constantin Burlacu2
1Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Abstract:
Cerebral ischemia reperfusion injury is a debilitating medical condition, currently with only a limited amount of therapies aimed at protecting the cerebral parenchyma. Micro RNAs (miRNAs) are small, non-coding RNA molecules that via the RNA-induced silencing complex either degrade or prevent target messenger RNAs from being translated and thus, can modulate the synthesis of target proteins. In the neurological field, miRNAs have been evaluated as potential regulators in brain development processes and pathological events. Following ischemic hypoxic stress, the cellular and molecular events initiated dysregulate different miRNAs, responsible for long-terming progression and extension of neuronal damage. Because of their ability to regulate the synthesis of target proteins, miRNAs emerge as a possible therapeutic strategy in limiting the neuronal damage following a cerebral ischemic event. This review aims to summarize the recent literature evidence of the miRNAs involved in signaling and modulating cerebral ischemia-reperfusion injuries, thus pointing their potential in limiting neuronal damage and repair mechanisms. An in-depth overview of the molecular pathways involved in ischemia reperfusion injury and the involvement of specific miRNAs, could provide future perspectives in the development of neuroprotective agents targeting these specific miRNAs.
Insights
MicroRNAs (miRNAs) show promise in treating cerebral ischemia reperfusion injury. These small RNA molecules regulate protein synthesis, offering a potential therapeutic strategy to limit neuronal damage and aid repair mechanisms after stroke.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Cerebral ischemia reperfusion injury is a severe condition with limited treatment options.
- MicroRNAs (miRNAs) are key regulators of gene expression, influencing protein synthesis.
- Dysregulation of miRNAs occurs after ischemic events, contributing to neuronal damage.
Purpose of the Study:
- To review the role of miRNAs in cerebral ischemia reperfusion injury.
- To explore miRNAs as potential therapeutic targets for neuroprotection.
- To summarize molecular pathways and specific miRNAs involved in injury and repair.
Main Methods:
- Literature review of studies on miRNAs in cerebral ischemia reperfusion injury.
- Analysis of molecular mechanisms underlying miRNA involvement.
- Identification of specific miRNAs and their target pathways.
Main Results:
- miRNAs play a significant role in modulating cellular and molecular events post-ischemia.
- Specific miRNAs are implicated in both the progression and potential resolution of neuronal damage.
- miRNA-based therapies offer a novel approach to neuroprotection.
Conclusions:
- miRNAs represent a promising therapeutic avenue for managing cerebral ischemia reperfusion injury.
- Targeting specific miRNAs could limit neuronal damage and promote brain repair.
- Further research into miRNA pathways may lead to the development of new neuroprotective agents.

